Only 3 days until the B.A.A.–Mass General Brigham Cancer Institute 10K! Join me and our amazing Solid Tumor Oncology team as we run to support cancer research and the patients/families we serve. Can’t make it? Please consider donating: fundraise.massgeneralbrigham.org/fundraiser/718…
Justin Gainor
@JustinGainor
Director, Center for Thoracic Cancers Program; Director, Targeted Immunotherapy; Mass General Hospital, Harvard Medical School. Views my own.
469 Following 2.8K Followers 329 Posts
Latest posts 5
Collaborative study between MGB Thoracic and Haber, Mishra, Toner and Maheswaran labs shows DLL3 CTCs are highly predictive for outcomes with tarlatamab in SCLC. Also provide insights into CRS and mechanisms of resistance. aacrjournals.org/cancerdiscover…
Join me and our amazing faculty at our annual CME - "Advances in Cancer Immunotherapy" on Nov 14-15th. Registration is now open. This course has something from everyone! @MGHCancerCenter @harvardmed cpdlearn.massgeneralbrigham.org/course/advance…
Fantastic presentations by @MGHThoracicOnc team members @JessicaJLinMD and @ZPiotrowskaMD at #ASCO2023 outlining mechanisms of resistance and next gen targeted therapies
Superstar fellow @alissajcooper of @MGHThoracicOnc presents initial results from the global RETgistry of >100 post RET TKI biopsies to define mechanisms of resistance #happylungs @JessicaJLinMD @alexdrilon @RETpositive @RetRenegades @MSKCancerCenter